WORK Medical (WOK) announced that it has entered into a strategic cooperation agreement with Novabioplus. The two parties aim to jointly develop a “Data-Model-Application” trinity of next-generation intelligent medical models. The long-term initiative aims to integrate WORK Medical’s digital transformation of AI-driven healthcare with Novabioplus’ extensive protein data resources and application scenarios, unlocking the latent value of biological data assets. Pursuant to the agreement, the parties agree to integrate WORK Medical’s AI algorithms expertise with Novabioplus’ protein datasets and multi-dimensional biological reagent platforms to propel the R&D of AI-driven protein antibody therapeutics.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WOK:
